Kompa, Benjamin
Hakim, Joe B.
Palepu, Anil
Kompa, Kathryn Grace
Smith, Michael
Bain, Paul A.
Woloszynek, Stephen
Painter, Jeffery L.
Bate, Andrew
Beam, Andrew L.
Funding for this research was provided by:
GlaxoSmithKline
Article History
Accepted: 13 March 2022
First Online: 17 May 2022
Change Date: 24 February 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40264-023-01273-9
Declarations
:
: GlaxoSmithKline (GSK) was a sponsor of this project and provided funding to Harvard. No additional external funding was received for the conduct of this study or the preparation of this article.
: Jeffery L. Painter and Andrew Bate were current full-time employees and stockholders of GSK at the time this study was completed. Benjamin Kompa, Joe B. Hakim, Anil Palepu, Kathryn Grace Kompa, Michael Smith, Paul A. Bain, Stephen Woloszynek, and Andrew L. Beam have no conflicts of interest to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: The datasets generated and/or analyzed during this scoping review are available on Github (). All references included in the final analysis are available in the ‘references’ folder in the repo. Additionally, a companion website to our review is available at.
: The code to reproduce our figures and LDA analysis is available at
: Conceptualization: AB, ALB. Methodology: BK, JBH, PAB, SW, JLP, AB, ALB. Query formation: BK, JBH, PAB, JLP, AB, ALB. Abstract review: BK, JBH, AP, KGK, MS, SW, ALB. Abstract review conflict adjudication: BK, ALB. Full-text review: BK, JBH, AP, KGK, MS, SW, ALB. Full-text conflict adjudication: BK, ALB. Data extraction: BK, JBH, AP, KGK, MS, ALB. Formal analysis and investigation: BK, SW, ALB. Writing – original draft preparation: BK, ALB. Writing – review and editing: BK, JLP, AB, ALB. Funding acquisition: AB, ALB. Resources: AB, ALB. Supervision: AB, ALB.All authors read and approved the final version.